Suchergebnisse - "Antirheumatic Agents"

PubPharm (4.384)

41

The effect of anti-TNF on renal function in patients with ankylosing spondylitis : a prospective cohort study

enthalten in: Clinical rheumatology | 2022

von Swart, I. | Visman, I. | Heslinga, M. | +3

42

Efficacy and Safety of Intravenous Golimumab in Patients With Ankylosing Spondylitis and Complete Spinal Ankylosis : Results Through Week 52 of the GO-ALIVE Study

enthalten in: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases | 2022

von Deodhar, A. | Chakravarty, S. | Shiff, N. | +5

43

Olokizumab, a monoclonal antibody against interleukin-6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by tumour necrosis factor inhibitor therapy : efficacy and safety results of a randomised controlled phase III study

enthalten in: Annals of the rheumatic diseases | 2022

von Feist, E. | Fatenejad, S. | Grishin, S. | +6

44

The effect of risankizumab on achieving minimal clinically important differences in patient-reported outcomes in patients with psoriatic arthritis : results from KEEPsAKE 1 and 2

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2022

von Kristensen, L. | Soliman, A. | Papp, K. | +3

45

First-line biologic therapy with tumor necrosis factor inhibitors for psoriatic arthritis : a prospective observational study

enthalten in: Sao Paulo medical journal = Revista paulista de medicina | 2022

von Silva, M. | Santos, J. | Kakehasi, A. | +4

46

Therapeutic Utility and Adverse Effects of Biologic Disease-Modifying Anti-Rheumatic Drugs in Inflammatory Arthritis

enthalten in: International journal of molecular sciences | 2022

von Min, H. | Kim, S. | Kim, H. | +1

47

Phase II/III Results of a Trial of Anti-Tumor Necrosis Factor Multivalent NANOBODY Compound Ozoralizumab in Patients With Rheumatoid Arthritis

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2022

von Takeuchi, T. | Kawanishi, M. | Nakanishi, M. | +2

48

Drug-induced interstitial lung disease

enthalten in: The European respiratory journal | 2022

von Spagnolo, P. | Bonniaud, P. | Rossi, G. | +2

49

Impact of pre-existing background therapy on placebo responses in randomised controlled clinical trials of rheumatoid arthritis

enthalten in: Annals of the rheumatic diseases | 2022

von Kerschbaumer, A. | Rivai, Z. | Smolen, J. | +1

50

Anti-TNFα drug levels in patients with rheumatoid arthritis and spondyloarthritis

enthalten in: Reumatologia clinica | 2022

von Meriño-Ibarra, E. | Manero Ruíz, F.